970 related articles for article (PubMed ID: 24805797)
1. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.
Grosso G; Pajak A; Marventano S; Castellano S; Galvano F; Bucolo C; Drago F; Caraci F
PLoS One; 2014; 9(5):e96905. PubMed ID: 24805797
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.
Mocking RJ; Harmsen I; Assies J; Koeter MW; Ruhé HG; Schene AH
Transl Psychiatry; 2016 Mar; 6(3):e756. PubMed ID: 26978738
[TBL] [Abstract][Full Text] [Related]
3. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
Martins JG
J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression.
Sublette ME; Ellis SP; Geant AL; Mann JJ
J Clin Psychiatry; 2011 Dec; 72(12):1577-84. PubMed ID: 21939614
[TBL] [Abstract][Full Text] [Related]
5. The role of n-3 polyunsaturated fatty acids (n-3PUFAs) in affective disorders.
Ciappolino V; Delvecchio G; Agostoni C; Mazzocchi A; Altamura AC; Brambilla P
J Affect Disord; 2017 Dec; 224():32-47. PubMed ID: 28089169
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 polyunsaturated fatty acid (n-3 PUFA) supplementation for prevention and treatment of perinatal depression: a systematic review and meta-analysis of randomized-controlled trials.
Suradom C; Suttajit S; Oon-Arom A; Maneeton B; Srisurapanont M
Nord J Psychiatry; 2021 May; 75(4):239-246. PubMed ID: 33190574
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.
Downie LE; Ng SM; Lindsley KB; Akpek EK
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011016. PubMed ID: 31847055
[TBL] [Abstract][Full Text] [Related]
8. Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials.
Kelaiditis CF; Gibson EL; Dyall SC
Prostaglandins Leukot Essent Fatty Acids; 2023 May; 192():102572. PubMed ID: 37028202
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acids for bipolar disorder.
Montgomery P; Richardson AJ
Cochrane Database Syst Rev; 2008 Apr; (2):CD005169. PubMed ID: 18425912
[TBL] [Abstract][Full Text] [Related]
10. High-dose omega-3 polyunsaturated fatty acid supplementation might be more superior than low-dose for major depressive disorder in early therapy period: a network meta-analysis.
Luo XD; Feng JS; Yang Z; Huang QT; Lin JD; Yang B; Su KP; Pan JY
BMC Psychiatry; 2020 May; 20(1):248. PubMed ID: 32434488
[TBL] [Abstract][Full Text] [Related]
11. Low omega-3 polyunsaturated fatty acids predict reduced response to standard antidepressants in patients with major depressive disorder.
Cussotto S; Delgado I; Oriolo G; Kemper J; Begarie D; Dexpert S; Sauvant J; Leboyer M; Aouizerate B; Martin-Santos R; Schaefer M; Capuron L
Depress Anxiety; 2022 May; 39(5):407-418. PubMed ID: 35357051
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis.
Bloch MH; Hannestad J
Mol Psychiatry; 2012 Dec; 17(12):1272-82. PubMed ID: 21931319
[TBL] [Abstract][Full Text] [Related]
13. Eicosapentaenoic and docosahexaenoic acids have different effects on peripheral phospholipase A2 gene expressions in acute depressed patients.
Su KP; Yang HT; Chang JP; Shih YH; Guu TW; Kumaran SS; Gałecki P; Walczewska A; Pariante CM
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):227-233. PubMed ID: 28648567
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?
Ross BM; Seguin J; Sieswerda LE
Lipids Health Dis; 2007 Sep; 6():21. PubMed ID: 17877810
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 Polyunsaturated Fatty Acids for Core Symptoms of Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
Liu TH; Wu JY; Huang PY; Lai CC; Chang JP; Lin CH; Su KP
J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37656283
[No Abstract] [Full Text] [Related]
16. Omega-3 polyunsaturated fatty acids in cardiovascular diseases comorbid major depressive disorder - Results from a randomized controlled trial.
Chang JP; Chang SS; Yang HT; Chen HT; Chien YC; Yang B; Su H; Su KP
Brain Behav Immun; 2020 Mar; 85():14-20. PubMed ID: 30902738
[TBL] [Abstract][Full Text] [Related]
17. Effects of n-3 Polyunsaturated Fatty Acid Supplementation in the Prevention and Treatment of Depressive Disorders-A Systematic Review and Meta-Analysis.
Wolters M; von der Haar A; Baalmann AK; Wellbrock M; Heise TL; Rach S
Nutrients; 2021 Mar; 13(4):. PubMed ID: 33806078
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials.
Casula M; Olmastroni E; Gazzotti M; Galimberti F; Zambon A; Catapano AL
Pharmacol Res; 2020 Oct; 160():105060. PubMed ID: 32634581
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized controlled trial.
Chang JP; Chang SS; Chen HT; Chien YC; Yang HT; Huang SY; Tseng PT; Chang CH; Galecki P; Su KP
Brain Behav Immun; 2023 Aug; 112():125-131. PubMed ID: 37301235
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression.
Hallahan B; Ryan T; Hibbeln JR; Murray IT; Glynn S; Ramsden CE; SanGiovanni JP; Davis JM
Br J Psychiatry; 2016 Sep; 209(3):192-201. PubMed ID: 27103682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
